Literature DB >> 11586010

Psychosocial impact of acne vulgaris. evaluation of the relation between a change in clinical acne severity and psychosocial state.

M M Mulder1, V Sigurdsson, E J van Zuuren, E J Klaassen, J A Faber, J B de Wit, W A van Vloten.   

Abstract

BACKGROUND: Although knowledge concerning the impact of acne vulgaris on quality of life has increased in recent years, relatively few studies have assessed the effect of a change in clinical severity on psychosocial state.
OBJECTIVE: Assessment of the effect of a change in clinical acne severity on psychosocial state.
METHODS: This was investigated by means of questionnaires and clinical assessments by acne patients and dermatologists. Fifty females with mild to moderate facial acne were seen before and after a 9-month treatment with oral contraceptives.
RESULTS: The results showed a great variability in psychosocial impairment between individuals. After 9 months, a significant reduction in clinical severity was seen overall which did not relate to the significant improvements in self-esteem, stability of self-esteem and acceptance of appearance.
CONCLUSION: Perceived psychosocial impairment is individually based, is greater in women who subjectively overrate their acne and does not relate to clinical improvement. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11586010     DOI: 10.1159/000051726

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  12 in total

1.  Psychological sequelae of acne vulgaris: results of a qualitative study.

Authors:  Parker Magin; Jon Adams; Gaynor Heading; Dimity Pond; Wayne Smith
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

2.  Inflammatory Acne in the Asian Skin Type III Treated with a Square Pulse, Time Resolved Spectral Distribution IPL System: A Preliminary Study.

Authors:  Geun-Soo Lee
Journal:  Laser Ther       Date:  2012-07-03

3.  Psychosocial Impact of Postinflammatory Hyperpigmentation in Patients with Acne Vulgaris.

Authors:  Kavita Darji; Reena Varade; Daniel West; Eric S Armbrecht; Mary A Guo
Journal:  J Clin Aesthet Dermatol       Date:  2017-05-01

4.  Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?

Authors:  Whitney P Bowe; Alan C Logan
Journal:  Gut Pathog       Date:  2011-01-31       Impact factor: 4.181

5.  Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles.

Authors:  Whitney P Bowe; Alan C Logan
Journal:  Lipids Health Dis       Date:  2010-12-09       Impact factor: 3.876

6.  Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: a national population-based study.

Authors:  Yi-Chien Yang; Hung-Pin Tu; Chien-Hui Hong; Wei-Chao Chang; Hung-Chun Fu; Ji-Chen Ho; Wei-Pin Chang; Hung-Yi Chuang; Chih-Hung Lee
Journal:  Biomed Res Int       Date:  2014-02-11       Impact factor: 3.411

7.  Quality of life in patients with skin diseases in central Saudi Arabia.

Authors:  Mostafa A Abolfotouh; Mohammad S Al-Khowailed; Wijdan E Suliman; Deema A Al-Turaif; Eman Al-Bluwi; Hassan S Al-Kahtani
Journal:  Int J Gen Med       Date:  2012-07-24

8.  Acne-specific quality of life questionnaire (Acne-QoL): translation, cultural adaptation and validation into Brazilian-Portuguese language.

Authors:  Cristhine de Souza Leão Kamamoto; Karime Marques Hassun; Ediléia Bagatin; Jane Tomimori
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

9.  Translation, cultural adaptation and validation for Brazilian Portuguese of the Cardiff Acne Disability Index instrument.

Authors:  Luciana Rosa Grando; Roberta Horn; Vivian Trein Cunha; Tania Ferreira Cestari
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

Review 10.  The prevalence of acne in Mainland China: a systematic review and meta-analysis.

Authors:  Danhui Li; Qiang Chen; Yi Liu; Tingting Liu; Wenhui Tang; Shengjie Li
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.